financetom
Business
financetom
/
Business
/
Blackstone and Legal & General agree private credit tie-up
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Blackstone and Legal & General agree private credit tie-up
Jul 9, 2025 11:40 PM

LONDON, July 10 (Reuters) - British insurer Legal &

General ( LGGNF ) has entered into a private credit partnership

with Blackstone, the companies said in a statement on

Thursday, becoming the latest finance firm to bulk up in the

booming market of investors lending to companies.

L&G, which is also Britain's largest investment firm

with 1.1 trillion pounds ($1.5 trillion) of assets under

management, said the tie-up would help it strengthen in two

areas targeted by CEO Antonio Simoes: the United States and

private credit.

The British firm said its annuities business would

access investment-grade credit assets via Blackstone,

particularly in the U.S., investing up to 10% of the unit's new

business flows.

Simoes said in the statement that the partnership with

Blackstone would help it meet growing demand from clients for

public-private investment products.

"L&G will benefit from a more diverse pipeline of assets

for our annuity book, and growth in asset management as we

develop more sophisticated investment solutions for clients

around the world," Simoes said.

The partnership was first reported by Bloomberg News.

($1 = 0.7349 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fiera Capital Q3 revenue slightly misses estimates
Fiera Capital Q3 revenue slightly misses estimates
Nov 13, 2025
Overview * Fiera Capital ( FRRPF ) Q3 revenue slightly misses analyst expectations * Adjusted EPS for Q3 meets analyst estimates * Company achieved positive net organic growth in AUM, driven by new relationships Outlook * Company did not provide specific guidance for future quarters or full year Result Drivers * NET ORGANIC GROWTH - Positive net organic growth of...
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Nov 13, 2025
Overview * Palatin fiscal Q1 2026 revenue rises to $8.8 mln, driven by Boehringer Ingelheim agreement * Company reports fiscal Q1 net income of $4.7 mln, reversing a loss from last year * Palatin ( PTN ) completes $18.2 mln public offering, regains NYSE American compliance Outlook * Company plans IND submission and Phase 1 trial for PL7737 in first...
Xilio Therapeutics' Q3 collaboration revenue rises
Xilio Therapeutics' Q3 collaboration revenue rises
Nov 13, 2025
Overview * Xilio Q3 collaboration revenue rises to $19.1 mln from $2.3 mln year-over-year * Net loss for Q3 widens to $16.3 mln from $14.0 mln year-over-year * Company anticipates cash runway into Q1 2027 Outlook * Xilio plans to submit IND for XTX501 in mid-2026 * Company anticipates cash runway into Q1 2027 * Xilio seeks partner for vilastobart...
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
Nov 13, 2025
07:43 AM EST, 11/13/2025 (MT Newswires) -- HLS Therapeutics ( HLTRF ) said Thursday that third-quarter net loss narrowed slightly as revenue rose. Net loss improved to US$3.92 million, or $0.12 per share, from a loss of $4.84 million, or $0.15 per share in the prior year period. Revenue decreased 4% to $13.5 million, primarily due to lower Clozaril Canada...
Copyright 2023-2026 - www.financetom.com All Rights Reserved